Abbreviations and Acronyms BMI = body mass index CI = confidence interval CKD = chronic kidney disease Cr = creatinine CT = computed tomography DL = dyslipidemia DM = diabetes mellitus eGFR = estimated glomerular filtration rate HT = hypertension OR = odds ratio PA = primary aldosteronism PAC = plasma aldosterone concentration Postop = postoperative PRA = plasma renin activity Preop = preoperative SD = standard deviation Objective: To investigate kidney function change during adrenalectomy in patients with primary aldosteronism and assess predictors of kidney function decline. Methods: The present study included 90 patients who underwent adrenalectomy for primary aldosteronism between 2004 and 2017. Kidney function was evaluated 1 month after surgery. Predictors associated with a ≥10% decline in the estimated glomerular filtration rate were investigated. Kidney parenchymal volume was compared before and after surgery in 10 patients using volumetric studies. Results: The mean estimated glomerular filtration rate decline in the total cohort at 1 month after surgery was 13.3% (before: 72.9 mL/min/1.73 m 2 , after: 64.9 mL/min/ 1.73 m 2 , P < 0.0001). The mean serum plasma aldosterone concentration (before: 373 pg/ mL vs after: 78 pg/mL, P < 0.0001) and potassium level (before: 3.7 mEq/L vs after: 3.9 mEq/L, P = 0.0001) were also significantly different after surgery. Age (odds ratio 6.37, P = 0.0006), preoperative plasma aldosterone concentration (odds ratio 3.12, P = 0.0209) and preoperative serum potassium level (odds ratio 2.87, P = 0.0010) were independent predictors of a ≥10% decline in estimated glomerular filtration rate. Volumetric studies in 10 patients showed that mean postoperative parenchymal volume was significantly decreased compared with the preoperative volume (263 cc vs 312 cc, P = 0.0003), with decreases in estimated glomerular filtration rate from 63 to 56 mL/min/1.73 m 2 (P = 0.0146). Conclusions: Kidney function deterioration after adrenalectomy can be detected in patients with primary aldosteronism. Age, preoperative plasma aldosterone concentration and preoperative potassium level are significant predictors of a decrease in the estimated glomerular filtration rate. Normal parenchymal volume decreases in line with renal functional deterioration.
Introduction
PA is characterized by autonomous aldosterone secretion from an adrenocortical lesion, and is mainly caused by unilateral aldosterone-producing adenoma or bilateral adrenal hyperplasia (also known as idiopathic hyperaldosteronism). 1 PA is a common cause of secondary HT, and recent studies have reported that PA affects 5-10% of hypertensive patients. 2 Patients generally present with high aldosterone levels, low PRA and HT as a result of increased sodium reabsorption and potassium excretion. The disease leads to renal HT and glomerular hyperfiltration. [3] [4] [5] [6] [7] [8] Several studies have reported kidney function deterioration after adrenalectomy in patients with PA. 9 Furthermore, some studies have suggested that impaired kidney function is masked by glomerular hyperfiltration due to chronically elevated aldosterone levels before surgery, [10] [11] [12] [13] and that the actual renal function is only revealed when the aldosterone level decreases after surgery. Although the etiology of this functional deterioration is unclear in patients with PA, there are some speculative ideas, such as endothelial dysfunction or increased small vessel resistance. 14, 15 In one case report, measuring kidney size before and after adrenalectomy showed that it had decreased during the operation. 16 This demonstrates that kidney hypertrophy as a result of glomerular hyperfiltration might modify kidney function in patients with PA. 16 However, the study only included two cases, meaning that its sample size was too limited to show a statistically significant difference in kidney size. A decline in kidney function, especially CKD, is known as a risk factor for death, cardiovascular events and hospitalization. 17 Detecting patients with masked deterioration in kidney function is important, because early intervention can be initiated in these patients to prevent the progression to advanced-stage CKD.
In the present study, we used a relatively large cohort of patients who underwent adrenalectomy to investigate the degree of postoperative change in kidney function and to assess predictive factors for postoperative kidney function decline. In addition, we compared the normal kidney parenchymal volume between the pre-and postoperative states in selected patients to investigate the etiology of kidney function decline after surgery.
Methods Patients
We enrolled 116 patients who underwent adrenalectomy for PA between 2004 and 2017 at a single institution. Patients with pre-existing end-stage renal disease and without sufficient laboratory data with respect to postoperative renal function were excluded; eventually, 90 patients were enrolled. Kidney function was evaluated 1 month after adrenalectomy. The main outcome investigated in the present study was the kidney function change between the pre-and postoperative states. We also sought to investigate predictive factors for kidney function deterioration. After calculating kidney function change, the cohort was divided into two groups: those who developed a ≥10% decline in eGFR at 1 month after surgery and those who did not. The following characteristics were compared between the two groups: age, sex, BMI, presence of HT, presence of DM, presence of DL, serum Cr level, eGFR, PAC, PRA, serum sodium level, serum potassium level, tumor size and operative time. In addition, predictive factors for kidney function deterioration were analyzed.
All procedures involving human participants were carried out in accordance with the ethical standards of the relevant institutional and/or national research committee, and the 1964 Helsinki declaration and its later amendments or comparable ethical standards. IRB approved number: 4736.
Volumetric studies
Renal parenchymal volume was evaluated in 10 patients who underwent CT before and after surgery. The renal parenchyma, excluding the perirenal fat, collecting system and cyst, was measured. The volume was estimated from axial scans in the venous phase reconstructed at 5-mm intervals. Manual scripting was used to define the area of interest at each 5-mm level, with the defined areas subsequently summed to yield the total volume. One urologist, who was not involved with the surgery, measured the renal parenchymal volume.
Diagnosis of PA
Patients were diagnosed with PA on the basis of an elevation in PAC and an aldosterone-renin ratio of ≥200 pg/mL per ng/mL/h, in addition to the results of hormone tests, such as the saline loading test, captopril challenge test and furosemide loading test. In addition, a conformational diagnosis of aldosterone-producing adenoma was determined by localization using abdominal CT and adrenal venous sampling at our endocrinology department.
Kidney function
We calculated eGFR using the following equation established for the Japanese population by the Japanese Society of Nephrology: eGFR (mL/min/1.73 m 2 ) = 194 9 serum Cr À1.094 9 age À0.287 (90.739 if female). 18 
Statistical analysis
The results are presented as mean AE SD, as appropriate. Preand postoperative kidney functions were compared using paired t-tests. Pre-and postoperative changes in each continuous variable, such as BMI, eGFR, tumor size, operative time, PAC, PRA, serum sodium level and serum potassium level, were compared using t-tests. On the basis of receiver operating characteristic curve analysis, we divided the patients into two groups: those who did and did not have a ≥10% decline in eGFR. Predictors associated with a ≥10% decline in eGFR were investigated in univariate analysis and multivariate logistic regression analysis. Comparison of kidney parenchymal volume between the pre-and postoperative states was carried out using t-tests. In all tests, statistical significance was defined at P < 0.05. JMP Pro version 13.0 software (SAS Institute, Cary, NC, USA) was used for all statistical analyses.
Results Table 1 shows the patient characteristics and changes in parameters, including kidney function, after surgery. The mean age was 51.2 years, and 50% of patients were men. The mean BMI was 23.9 kg/m 2 , and 10% of patients had DM. Most patients had HT (86 patients, 96%). Kidney function significantly deteriorated after surgery (Cr: 0.83 AE 0.27 mg/dL vs 0.95 AE 0.35 mg/dL, P < 0.0001; eGFR: 72.9 AE 19.4 mL/ min/1.73 m 2 vs 64.9 AE 19.9 mL/min/1.73 m 2 , P < 0.0001). Preoperative mean PAC was 373 AE 211 pg/mL, which significantly decreased after surgery (78 AE 45 pg/mL, P < 0.0001). Serum sodium level (before: 142 AE 1.9 mEq/L vs after: 141 AE 2.1 mEq/L, P = 0.0007) and serum potassium level (before: 3.7 AE 0.5 mEq/L vs after: 3.9 AE 0.4 mEq/L, P = 0.0001) were significantly different after surgery. PRA was not significantly different after surgery (P = 0.4772). Table 2 provides a comparison between patients who did and did not have a ≥10% decrease in eGFR. A total of 48 patients (53%) developed a ≥10% decrease in eGFR. Age (P = 0.0280), HT (P = 0.0438), preoperative PAC (P = 0.0090) and preoperative serum potassium level (P = 0.0029) were significantly different between the two groups. Table 3 shows the results of univariate and multivariate analyses of predictors of a ≥10% decline in eGFR at 1 month after surgery. In univariate analysis, older age (OR 2.82, P = 0.0226), higher preoperative PAC (OR 3.0, P = 0.0137) and preoperative lower serum potassium level (OR 2.87, P = 0.0152) were significantly associated with a ≥10% decline in eGFR. Multivariate analysis showed that age (OR 6.37, P = 0.0006), preoperative PAC (OR 3.12, P = 0.0209) and preoperative serum potassium level (OR 5.60, P = 0.0010) were also independent predictors of a ≥10% decline in eGFR. 
Discussion
The results of the present study showed significant kidney function deterioration after adrenalectomy in patients with PA. Furthermore, older age, higher preoperative PAC and lower preoperative potassium level were independent predictive factors for a ≥10% decline in eGFR after surgery. In addition, kidney parenchymal volume was significantly decreased in 10 selected patients after adrenalectomy.
In the present study, eGFR declined from 72.9 to 64.9 mL/min/1.73 m 2 (11% decline) (P < 0.0001) after surgery. Kidney function deterioration after adrenalectomy in patients with PA has been reported previously.
9,14 Utsumi et al. investigated eGFR decline according to preoperative kidney function, and reported a 16% decline in patients with preoperative eGFR ≥90 mL/min/1.73 m 2 , a 15% decline in those with eGFR 60-89 mL/min/1.73 m 2 and an 11% decline in those with eGFR <60 mL/min/1.73 m 2 . 9 This type of kidney function deterioration is known as "unmasked kidney function," which refers to kidney function impairment that is masked by hyperfiltration as a result of high aldosterone levels before surgery.
The etiology of kidney function impairment in patients with PA has been discussed in several previous studies. 7, 9, 14 Chronic HT and the direct effects of aldosterone reportedly induce kidney structural damage. 13 Aldosterone induces kidney function adaptations, which are induced by increased renal sodium reabsorption. These effects lead to expansion of extracellular volume, HT, increased renal perfusion pressure and suppression of renin with decreased intrarenal vascular resistance. 19 Glomerular hyperfiltration and structural damage usually occur as a result. Furthermore, aldosterone induces contraction more in efferent arterioles than in afferent arterioles, which increases glomerular capillary pressure. This glomerular HT is thought to cause glomerular structural damage. 20 In addition, aldosterone increases the levels of several kinds of cytokines, including transforming growth factor beta and fibronectin, which can cause renal fibrosis.
21
In the present study, the preoperative PAC level was significantly higher in patients who had a ≥10% decline in eGFR than in patients who did not (426 pg/mL vs 315 pg/ mL, P = 0.009). After surgery, PAC level did not differ significantly between these two groups (72 pg/mL vs 85 pg/mL, P = 0.3753). In addition, higher PAC levels were an independent predictor of a ≥10% decline in eGFR in the multivariate analysis (P = 0.0209). The association between aldosterone level and the degree of renal impairment has rarely been reported. Utsumi et al. analyzed clinical predictors of newonset eGFR <45 mL/min/1.73 m 2 in patients with PA, and found that the duration of HT and initial eGFR were independent predictors, whereas PAC level was not. 9 These findings do not correspond with those of the present study. In contrast, Kim et al. showed that high preoperative PAC is an independent predictive factor for postoperative renal impairment, which is a similar result to that of the present study. 14 As discussed above, aldosterone induces glomerular hyperfiltration. Furthermore, PAC might impact the degree of glomerular hyperfiltration, which could mask kidney function deterioration in patients with high PAC. In the present study, multivariate analysis showed that serum potassium level was a predictor of a ≥10% decline in eGFR after surgery. Some studies have reported an association between serum potassium level and kidney function. 15, 22 Rossi et al. found that low serum potassium level at baseline predicted albuminuria in 64 PA patients, 23 whereas Reincke et al. reported that hypokalemic PA patients tended to develop renal impairment. 22 In addition, it has also been reported that chronic hypokalemia can induce chronic renal failure through characteristic tubulointerstitial damage consisting of vacuolization of epithelial tubular cells and interstitial fibrosis. 24 The present study showed that low preoperative potassium levels predicted postoperative renal impairment. This implies that renal impairment was masked in patients with low serum potassium levels. The reasons for this association remain uncertain and should be assessed in more detail in future to determine the optimal treatment strategy for patients with PA.
Older age was an independent predictor of a ≥10% decline in eGFR after surgery in the present study. Kim et al. investigated kidney function impairment after adrenalectomy in 136 patients with PA and showed that old age was a significant risk factor for postoperative eGFR decline.
14 Several previous reports have suggested that older individuals might secrete less aldosterone and have lower PRA than younger people, which might account for the more significant changes in renal function in older patients. 25, 26 In the present study, there was no significant difference in preoperative PAC between the two groups divided according to age (<55 years: 374 pg/mL vs >55 years: 373 pg/mL, P = 0.7563). However, a significant difference was found in postoperative PAC (<55 years: 94 pg/ mL vs >55 years: 53 pg/mL, P < 0.0001), which might account for the association between age and decline in eGFR.
Despite the small number of patients assessed using volumetric studies in the present investigation, renal parenchymal volume was significantly decreased in line with the deterioration of kidney function. Park et al. investigated renal function and renal size after adrenalectomy in two patients with PA, and showed that the size of both kidneys decreased in line with kidney function deterioration after surgery. 16 This previous finding corresponds to that of the present study. High aldosterone level increases glomerular pressure, leading to glomerular hyperfiltration, which might result in glomerular hypertrophy. After surgery, improved aldosterone level unmasks kidney impairment and might also unmask the true kidney size.
The present study had some limitations that should be discussed. First, the study was retrospective in nature, carried out at a single institution and included a population of tertiary care patients. Second, some PA patients had already been administered hypertensive medications before they were referred to our department. This might have influenced the preoperative estimation of kidney function. In addition, serum potassium levels were controlled in some patients by medications, which might have impacted on the present results. Furthermore, the absence of data on mineralocorticoid receptor agonists and potassium supplementation could have been associated with preoperative potassium level. Third, other potential predictors of renal functional impairment, such as preoperative blood pressure, were not incorporated into our analyses because of a lack of sufficient clinical data. Fourth, to include as many patients as possible, we selected kidney function at 1 month after surgery as the postoperative kidney function outcome for the present study. Assessments of kidney function over longer periods could have shown different results. In addition, the long-term consequences of adrenalectomy in patients with PA, including HT and cardiovascular complications, were not investigated because the data were unavailable. Fifth, with respect to the volumetric studies carried out in 10 patients, the timing of postoperative imaging was different for each patient because these postoperative imaging studies were carried out for different reasons, such as screening for other diseases. However, such volumetric studies were rarely carried out in previous reports, and their use has been especially rare in studies of ≥10 patients. This represents one of the strengths of the present study. Other strengths of this study include the analysis of a relatively large sample of patients and the investigation of predictors of postoperative renal functional deterioration, such as PAC, age and serum potassium level. Our findings might help physicians to determine the appropriate surgical intervention for patients with PA.
In conclusion, the results of the present study provide evidence of kidney function decline after adrenalectomy in patients with PA. Older age, high preoperative PAC and low preoperative serum potassium level were risk factors for kidney function impairment. Despite the small number of patients assessed using volumetric analysis, kidney parenchymal volume was significantly decreased in line with the deterioration of kidney function. This finding suggests that glomerular hyperfiltration might modify kidney structure and function in patients with PA before surgery. According to the results of the present study, PAC, age and serum potassium levels were significant predictors of postoperative renal functional deterioration. Hence, masked kidney impairment should be taken into consideration when planning the appropriate treatment for patients with PA, especially those with any of the risk factors obtained in this study.
